APA (7th ed.) Citation

H, A., N, S., AM, G., I, G., H, B., A, M., . . . S, P. (2026). The CHRNA5 rs16969968 variant is associated with MMP-9 expression and inflammatory signaling in COPD in a West Bengal population, India. Frontiers in pharmacology, 17, 1841945. https://doi.org/10.3389/fphar.2026.1841945

Chicago Style (17th ed.) Citation

H, Adhikari, Sultana N, Goswami AM, Ganai I, Biswas H, Mondal A, Iqbal A, Moitra S, and Podder S. "The CHRNA5 Rs16969968 Variant Is Associated with MMP-9 Expression and Inflammatory Signaling in COPD in a West Bengal Population, India." Frontiers in Pharmacology 17 (2026): 1841945. https://doi.org/10.3389/fphar.2026.1841945.

MLA (9th ed.) Citation

H, Adhikari, et al. "The CHRNA5 Rs16969968 Variant Is Associated with MMP-9 Expression and Inflammatory Signaling in COPD in a West Bengal Population, India." Frontiers in Pharmacology, vol. 17, 2026, p. 1841945, https://doi.org/10.3389/fphar.2026.1841945.